Amino Acids China Monthly Report

Welcome to the Feb. issue of Amino Acids China E-News.

Company dynamics

• Sichuan Hebang released its annual performance forecast for 2025.
• Wuxi Jinghai's 2025 net profit expects a YoY increase over 40%.
• Yong'an Pharmaceutical's 2025 net profit expected to plunge over 50% YoY.

Project Progress

• SYEP's 40,000 t/a taurine project has been topped out.
• Nuopu Biotechnology's high-end amino acid industrialisation project passed acceptance inspection.
• Eppen Bio's valine technology renovation project passed acceptance check.
• Yilihong's agricultural and sideline products deep processing industry upgrade project (Phase I) passed acceptance check.
• EI report for Wuyi Health's 56,000 t/a MSG and 22,000 t/a various amino acid products project was publicised.

Governmental Direction

• EU imposed a definitive anti-dumping duty on China's valine.

Price Update

• In February 2026, methionine prices experienced a moderate rebound, with solid methionine increased by 7.29% and MHA-FA rose by 3.79% MoM.

Reminders

• The USD/CNY exchange rate in this newsletter is USD1.00=CNY6.9695, which was sourced from the People's Bank of China on 2 Feb., 2026. All the prices mentioned in this newsletter will include the VAT, unless otherwise specified.
• In this newsletter, the variance rates (MoM, QoQ, YoY, etc.) of all figures that involve RMB/USD conversion (prices, sales values, costs, etc.) are calculated with pre-conversion RMB prices/values, except for the figures in Import and Export column.